Skip to main content

Published locations for FDA committee recommends approval of tofacitinib for PsA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA committee recommends approval of tofacitinib for PsA

User login

  • Reset your password
  • /content/fda-committee-recommends-approval-tofacitinib-psa
  • /edermatologynews/article/143938/psoriatic-arthritis/fda-committee-recommends-approval-tofacitinib
  • /rheumatologynews/article/143938/psoriatic-arthritis/fda-committee-recommends-approval-tofacitinib
  • /rheumatology/article/143938/psoriatic-arthritis/fda-committee-recommends-approval-tofacitinib-psa
  • /dermatology/article/143938/psoriatic-arthritis/fda-committee-recommends-approval-tofacitinib-psa
  • /rheumatology/psoriatic-arthritis-resource-center/article/143938/psoriatic-arthritis/fda-committee
  • /dermatology/psoriasiscollection/article/143938/psoriatic-arthritis/fda-committee-recommends-approval
  • /psoriatic-arthritis-icymi/article/143938/psoriatic-arthritis/fda-committee-recommends-approval